TikaMobile Receives Award for Top 10 in the Life Sciences

The Life Sciences industry is currently experiencing a seismic shift, majorly driven by considerable external factors. The prominent players in the landscape, who heavily relied on highly popular drugs, are now facing a setback in the game due to the expiry of patents on a large scale. Moreover, customers’ expectations have increased rapidly over the years, leading researchers to identify measures to uproot the causes of diseases rather than curing patients after they are victimized. All these factors have made way for an ultimate disruption in the distribution channels, while Clinical Research Organizations (CROs) are struggling to cope up with the revised regulatory compliances. In the wake of this scenario, CROs are adopting high-end technological advancements to bridge the gap between the demand and supply of cure options.
TikaMobile - H (1)

To see the full article from CIO Review, click here